|
544403
|
A B Lifestyle
|
02-Feb-2026
|
Aditya Birla Lifestyle Brands Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025 (said results) and the issue of Non-Convertible Debentures on a private placement basis for an amount not exceeding Rs.500 Crores (Rupees Five Hundred Crores only) subject to such regulatory / statutory approvals as may be required.
|
|
524208
|
Aarti Industries
|
02-Feb-2026
|
Aarti Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter and Nine months ended December 31 2025.
|
|
500710
|
Akzo Nobel
|
02-Feb-2026
|
Quarterly Results
|
|
539277
|
Alstone Textiles
|
02-Feb-2026
|
Quarterly Results
Alstone Textiles (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 we hereby inform you that a meeting of Board of Directors of the Company will be held on Monday, 02nd of February, 2026 at the Registered Office of the Company at R-815 New Rajinder Nagar, North East, New Delhi, Delhi, India, 110060.
(As Per BSE Announcement Dated On : 27.01.2026)
|
|
519471
|
Ambar Protein
|
02-Feb-2026
|
Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 inter alia to consider and approve Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025
|
|
531681
|
Amerise BioScie
|
02-Feb-2026
|
Quarterly Results
Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday 2nd February 2026 inter alia, to consider following businesses: - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter and nine months ended as on 31st December 2025. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.
|
|
531991
|
Amraworld Agrico
|
02-Feb-2026
|
Quarterly Results
Amraworld Agrico Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday 2nd February 2026 inter alia, to consider following businesses: - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter and nine months ended as on 31st December 2025. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.
|
|
511038
|
Arco Leasing
|
02-Feb-2026
|
Quarterly Results
Arco Leasing Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 ,inter alia, to consider and approve un-audited financial results for Q3 of 2025-2026
|
|
542919
|
Artemis Medicare
|
02-Feb-2026
|
Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 inter alia to consider and approve (i) the Un-audited Financial Results (Standalone & Consolidated) for the quarter/ nine months period ended December 31 2025; and (ii) the proposal for raising of funds by way of issuance of any instrument or security including equity shares fully or partly convertible debentures non-convertible debentures along with warrants in one or more tranches including by way of preferential allotment or a private placement (including one or more Qualified Institutions Placements).
|
|
544397
|
Ather Energy
|
02-Feb-2026
|
Quarterly Results
Ather Energy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 ,inter alia, to consider and approve With reference to the captioned subject, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, February 02, 2026, inter-alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025.
|